Gilead’s Remdesivir Prevents Lung Damage In COVID-19 Study On Monkeys
Gilead Sciences Inc’s antiviral drug remdesivir prevented lung disease in macaque monkeys infected with the new coronavirus, according to a study published in the journal Nature. Two ampules of Ebola…
Share